Trial Profile
Randomized, open label, controlled clinical trial of eldcalcitol for falls prevention in postmenopausal osteoporotic patients with depression.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2019
Price :
$35
*
At a glance
- Drugs Eldecalcitol (Primary) ; Raloxifene
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 11 Sep 2013 New trial record